A detailed history of First Pacific Financial transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, First Pacific Financial holds 418 shares of NTLA stock, worth $5,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares
418
Previous 418 -0.0%
Holding current value
$5,839
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

BUY
$31.62 - $45.78 $13,217 - $19,136
418 New
418 $13,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.06B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track First Pacific Financial Portfolio

Follow First Pacific Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Pacific Financial, based on Form 13F filings with the SEC.

News

Stay updated on First Pacific Financial with notifications on news.